跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MONTELUKAST SANDOZ 5 montelukast 5 mg (as sodium) chewable tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
MONTELUKAST SANDOZ 5 montelukast 5 mg (as sodium) chewable tablet blister pack
Approved
STANDARD
MONTELUKAST SANDOZ 5 montelukast 5 mg (as sodium) chewable tablet blister pack
Accord Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2c3395be08e0b4a2
Company
Accord Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
2c3395be08e0b4a2
Product Name
MONTELUKAST SANDOZ 5 montelukast 5 mg (as sodium) chewable tablet blister pack
Artg Id
184833
Artg Name
MONTELUKAST SANDOZ 5 montelukast 5 mg (as sodium) chewable tablet blister pack
Sponsor
Accord Healthcare Pty Ltd
Company Detail Path
/organization/accord-healthcare-pty-ltd
Artg Date
2012-05-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d6bed16bfb234d15c1842c54faef69e3.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/8eb6b5dad1bf2f10674992bbdd8518a0.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2c3395be08e0b4a2
Type
Standard
Back to TGA Approvals